Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/CIMA-AEMPS/SUNITINIB PIRAMAL 25 MG CAPSULAS DURAS EFG

Approved

STANDARD

SUNITINIB PIRAMAL 25 MG CAPSULAS DURAS EFG

Piramal Critical Care B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jan 26, 2021
Approval ID: 5bcad0de57e99b5a
Company: Piramal Critical Care B.V.
Type: Standard

Approval Details

Approval Id: 5bcad0de57e99b5a
Drug Cima Aemps Name: SUNITINIB PIRAMAL 25 MG CAPSULAS DURAS EFG
Register Number: 85719
Holder Company Name: Piramal Critical Care B.V.
Marketing Company Name: Euromed Pharma Spain S.L.
Holder Company Detail Path: /organization/piramal-critical-care-bv
Authorization Date: 2021-01-26
Dosage Form: CÁPSULA DURA
Dose: 25 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Piramal Critical Care B.V.
Company Detail Path: /organization/piramal-critical-care-bv

Company Information

Pharmaceutical Company Name: Piramal Critical Care BV
Country Name: Netherlands
Website: http://www.piramal.com

Active Ingredients

SUNITINIB MALATO

33,4 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jan 26, 2021

Approval ID

5bcad0de57e99b5a

Type

Standard

Back to CIMA-AEMPS Approvals

SUNITINIB PIRAMAL 25 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details